These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25568952)
1. Effect of fitness on incident diabetes from statin use in primary prevention. Radford NB; DeFina LF; Barlow CE; Kerr A; Chakravorty R; Khera A; Levine BD Atherosclerosis; 2015 Mar; 239(1):43-9. PubMed ID: 25568952 [TBL] [Abstract][Full Text] [Related]
2. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels. Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986 [TBL] [Abstract][Full Text] [Related]
3. Statin therapy with or without ezetimibe and the progression to diabetes. Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961 [TBL] [Abstract][Full Text] [Related]
4. Statin Use and Incident Diabetes Explained by Bias Rather Than Biology. Blackburn DF; Chow JY; Smith AD Can J Cardiol; 2015 Aug; 31(8):966-9. PubMed ID: 26118448 [TBL] [Abstract][Full Text] [Related]
5. Statins, risk of diabetes, and implications on outcomes in the general population. Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288 [TBL] [Abstract][Full Text] [Related]
6. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Wei M; Gibbons LW; Mitchell TL; Kampert JB; Lee CD; Blair SN Ann Intern Med; 1999 Jan; 130(2):89-96. PubMed ID: 10068380 [TBL] [Abstract][Full Text] [Related]
7. Cardiorespiratory Fitness and Incidence of Type 2 Diabetes in United States Veterans on Statin Therapy. Kokkinos P; Faselis C; Narayan P; Myers J; Nylen E; Sui X; Zhang J; Lavie CJ Am J Med; 2017 Oct; 130(10):1192-1198. PubMed ID: 28552431 [TBL] [Abstract][Full Text] [Related]
8. Statin use and the risk of incident diabetes mellitus: a review of the literature. Colbert JD; Stone JA Can J Cardiol; 2012; 28(5):581-9. PubMed ID: 22658337 [TBL] [Abstract][Full Text] [Related]
9. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients. Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412 [TBL] [Abstract][Full Text] [Related]
10. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults. Mansi I; Frei CR; Wang CP; Mortensen EM J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657 [TBL] [Abstract][Full Text] [Related]
11. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536 [TBL] [Abstract][Full Text] [Related]
12. Cardiorespiratory fitness attenuates risk for major adverse cardiac events in hyperlipidemic men and women independent of statin therapy: The Henry Ford ExercIse Testing Project. Hung RK; Al-Mallah MH; Qadi MA; Shaya GE; Blumenthal RS; Nasir K; Brawner CA; Keteyian SJ; Blaha MJ Am Heart J; 2015 Aug; 170(2):390-9. PubMed ID: 26299238 [TBL] [Abstract][Full Text] [Related]
13. Statins for primary prevention in physically active individuals: Do the risks outweigh the benefits? Mansi IA; English JL; Morris MJ; Zhang S; Mortensen EM; Halm EA J Sci Med Sport; 2017 Jul; 20(7):627-632. PubMed ID: 28185810 [TBL] [Abstract][Full Text] [Related]
14. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women. Ma Y; Persuitte GM; Andrews C; Hovey KM; LaMonte MJ; Culver AL; Manson JE; Phillips LS; Liu S; Eaton C; Martin LW; Howard BV; Balasubramanian R; Bird CE; Ockene IS; Sturgeon SR; Ockene JK; Tinker L; Nassir R; Rossouw J Eur J Epidemiol; 2016 Aug; 31(8):747-61. PubMed ID: 27188186 [TBL] [Abstract][Full Text] [Related]
15. Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia. Skoumas J; Liontou C; Chrysohoou C; Masoura C; Aznaouridis K; Pitsavos C; Stefanadis C Atherosclerosis; 2014 Nov; 237(1):140-5. PubMed ID: 25238223 [TBL] [Abstract][Full Text] [Related]
16. Associations of statin use with glycaemic traits and incident type 2 diabetes. Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685 [TBL] [Abstract][Full Text] [Related]
17. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
18. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. LaMonte MJ; Barlow CE; Jurca R; Kampert JB; Church TS; Blair SN Circulation; 2005 Jul; 112(4):505-12. PubMed ID: 16009797 [TBL] [Abstract][Full Text] [Related]
19. Putting the diabetes risk due to statins in perspective: a re-evaluation using the complementary outcome. Furuya-Kanamori L; Stone JC; Doi SA Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):705-8. PubMed ID: 24780516 [TBL] [Abstract][Full Text] [Related]